Risk and Warning Statements

CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian.

WARNING: Keep out of the reach of children. Not for human use.
For customer service or to obtain product information, including Material Safety Data Sheet, call 1-800-633-3796.

CONTRAINDICATIONS: There are no known contraindications to the use of praziquantel in cats.

ADVERSE REACTIONS: One instance of diarrhea and one of salivation (1.5%) were reported during the field trials in which 135 cats were administered Droncit® Feline Cestocide.
For medical emergencies or to report adverse reactions, call 1-800-422-9874.

ANIMAL SAFETY: The safety index has been derived from controlled safety evaluations, clinical trials and prior approved use in foreign countries.
Dosages of 5 times the labeled rate at 14 day intervals to cats as young as 5 ½ weeks did not produce clinical signs of toxicity. No significant clinical chemistry, hematological, or histopathological changes occurred. Symptoms of gross overdosage include vomition, salivation, diarrhea and depression.

PREGNANCY: Droncit® (praziquantel) has been tested in breeding and pregnant cats. No adverse effects were noted.